Esperion Therapeutics Eulerpool News

Esperion Therapeutics Eulerpool News

Esperion Therapeutics Notizie Azioni

Esperion Therapeutics è seguito da molti giornalisti e investitori in tutto il mondo. Qui raccogliamo le più recenti notizie Esperion Therapeutics.

• 11 settembre ·

  Yahoo
  Why Is Esperion Therapeutics (ESPR) Down 3.9% Since Last Earnings Report?
• 5 settembre ·

  Yahoo
  Esperion to Participate in Upcoming 2024 Cantor Global Healthcare Conference
• 4 settembre ·

  Stock Options Channel
  Commit To Purchase Esperion Therapeutics At $1.50, Earn 36% Annualized Using Options
• 3 settembre ·

  Yahoo
  Esperion Secures Additional Commercial and Medicare Formulary Coverage for NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe)
• 3 settembre ·

  TipRanks
  Market Outperform: Enhanced Insurance Coverage and FDA Approvals Propel Esperion’s Growth Potential
• 3 settembre ·

  GlobeNewswire
  Esperion Secures Additional Commercial and Medicare Formulary Coverage for NEXLETOL? (bempedoic acid) and NEXLIZET? (bempedoic acid and ezetimibe)
• 3 settembre ·

  Thefly.com
  Esperion secures additional commercial, Medicare formulary coverage for NEXLETOL
• 26 agosto ·

  Yahoo
  Esperion to Participate in Upcoming H.C. Wainwright 26th Annual Global Investment Conference
• 19 agosto ·

  SeekingAlpha
  Esperion Therapeutics: Delivering On Expectations While Navigating Overhangs
• 16 agosto ·

  SeekingAlpha
  Esperion Therapeutics: Strategically Positioned To Grow